Mirabegron cost?

The cost of Mirabegron, a medication used to treat overactive bladder, varies significantly based on factors such as dosage, quantity, insurance coverage, and pharmacy.

What factors influence the price of Mirabegron?

The retail price of Mirabegron can range widely. For instance, a 30-day supply of 25 mg tablets might cost around \$400, while a 30-day supply of 50 mg tablets could be approximately \$500. These prices are often subject to discounts and coupons offered by manufacturers or pharmacies. The availability of generic versions also plays a crucial role in determining the overall cost.

How much does generic Mirabegron cost?

Generic versions of Mirabegron are available, which typically leads to a substantial reduction in price compared to the brand-name drug. For example, a 30-day supply of generic Mirabegron 25 mg tablets can be found for as low as \$70 to \$100, and the 50 mg strength might cost between \$80 and \$110 for the same duration. These generic options are often provided by multiple pharmaceutical companies, increasing competition and potentially driving prices down further.

Where can I find discount coupons for Mirabegron?

Savings cards and coupons are frequently available for both brand-name and generic Mirabegron. These can be obtained from the manufacturer's website, online coupon aggregators, or directly from pharmacies. Some savings programs may offer significant discounts, reducing the out-of-pocket cost for eligible patients. For example, a savings card might limit patient costs to a set amount per prescription fill.

How does insurance coverage affect Mirabegron cost?

Insurance coverage has a significant impact on the final cost of Mirabegron. Most insurance plans include Mirabegron in their formularies, but copayment amounts vary. Patients with commercial insurance might pay between \$10 and \$60 for a 30-day supply, depending on their specific plan's benefits. Medicare Part D plans also cover Mirabegron, with copays typically ranging from \$0 to \$50 for a 30-day supply. Some plans may require prior authorization or have specific step-therapy requirements before covering the medication.

When does Mirabegron patent exclusivity end?

The patent exclusivity for the brand-name Mirabegron, sold as Myrbetriq, has largely expired in many regions, paving the way for generic competition. For example, U.S. patent exclusivity for certain aspects of Myrbetriq has ended, allowing generic manufacturers to enter the market. Information on specific patent expiration dates for Mirabegron can be found on resources like DrugPatentWatch.com [1].

Who are the major manufacturers of generic Mirabegron?

Several pharmaceutical companies are manufacturing and distributing generic Mirabegron. These include manufacturers like Teva Pharmaceuticals, Mylan (now Viatris), and Aurobindo Pharma, among others. The presence of multiple generic suppliers contributes to a more competitive market.